| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Kimmel Cancer Center, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania 19107 [A. V., H. I., F. T., J. F. T., Y. M., H. A., C. M. C., R. B.]; Laboratory of Comparative Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center, NIH, Frederick, Maryland 21702 [Y-H. S.]; and Department of Pathology, University of Padova, Padova 35126, Italy [M. R.].
Purpose: Loss of heterozygosity (LOH) involving the short arm of chromosome 8 (8p) is a common feature of the malignant progression of human tumors, including gastric cancer. We have cloned and mapped a candidate tumor suppressor gene, FEZ1/LZTS1, to 8p22. Here we have analyzed whether FEZ1/LZTS1 alterations play a role in the development and progression of gastric carcinoma.
Experimental Design: We examined Fez1/Lzts1 expression in 8 gastric carcinoma cell lines by Western blot, and in 88 primary gastric carcinomas by immunohistochemistry. Twenty-six of these 88 primary gastric carcinomas were also microdissected and tested for LOH at the FEZ1/LZTS1 locus and for mutation of the FEZ1/LZTS1 gene. Furthermore, we studied the FEZ1/LZTS1 gene regulation and transcriptional control and the methylation status of the 5' region of the gene in all 8 gastric carcinoma cell lines.
Results: Fez1/Lzts1 protein was barely detectable in all of the gastric cancer cell lines tested and was absent or significantly reduced in 39 of the 88 (44.3%) gastric carcinomas analyzed by immunohistochemistry, with a significant correlation (P < 0.001) to diffuse histotype. DNA allelotyping analysis showed allelic loss in 3 of 17 (18%) and microsatellite instability in 4 of 17 (23.5%) cases informative for D8S261 at the FEZ1/LZTS1 locus. When we compared the presence of LOH with Fez1/Lzts1 expression, we found loss of protein expression in all three of the tumors with allelic imbalance at D8S261. A missense mutation was detected in one case that did not express Fez1/Lzts1. Hypermethylation of the CpG island flanking the Fez1/Lzts1 promoter was evident in six of the eight cell lines examined as well as in the normal control.
Conclusions: Our findings support FEZ1/LZTS1 as a candidate tumor suppressor gene at 8p in a subtype of gastric cancer and suggest that its inactivation is attributable to several factors including genomic deletion and methylation.
This article has been cited by other articles:
|
|
 |
|
  R. Baffa, M. Fassan, C. Sevignani, A. Vecchione, H. Ishii, E. Giarnieri, R. V. Iozzo, L. G. Gomella, and C. M. Croce Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis Carcinogenesis, April 1, 2008; 29(4): 846 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Thyssen, T.-H. Li, L. Lehmann, M. Zhuo, M. Sharma, and Z. Sun LZTS2 Is a Novel {beta}-Catenin-Interacting Protein and Regulates the Nuclear Export of {beta}-Catenin Mol. Cell. Biol., December 1, 2006; 26(23): 8857 - 8867. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Nonaka, A. Fabbri, L. Roz, L. Mariani, A. Vecchione, G. W. Moore, L. Tavecchio, C. M. Croce, and G. Sozzi Reduced FEZ1/LZTS1 Expression and Outcome Prediction in Lung Cancer Cancer Res., February 15, 2005; 65(4): 1207 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. French, G. Petroni, S. N. Thibideau, M. Smolkin, E. Bissonette, F. Roviello, J. C. Harper, B. R. Koch, S. A. Anderson, S. J. Hebbring, et al. Allelic Imbalance of 8p Indicates Poor Survival in Gastric Cancer J. Mol. Diagn., August 1, 2004; 6(3): 243 - 252. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Toyooka, Y. Fukuyama, I. I. Wistuba, M. S. Tockman, J. D. Minna, and A. F. Gazdar Differential Expression of FEZ1/LZTS1 Gene in Lung Cancers and Their Cell Cultures Clin. Cancer Res., July 1, 2002; 8(7): 2292 - 2297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Vecchione, H. Ishii, G. Baldassarre, P. Bassi, F. Trapasso, H. Alder, F. Pagano, L. G. Gomella, C. M. Croce, and R. Baffa FEZ1/LZTS1 Is Down-Regulated in High-Grade Bladder Cancer, and Its Restoration Suppresses Tumorigenicity in Transitional Cell Carcinoma Cells Am. J. Pathol., April 1, 2002; 160(4): 1345 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ishii, A. Vecchione, Y. Murakumo, G. Baldassarre, S. Numata, F. Trapasso, H. Alder, R. Baffa, and C. M. Croce FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis PNAS, August 10, 2001; (2001) 181222898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ishii, A. Vecchione, Y. Murakumo, G. Baldassarre, S. Numata, F. Trapasso, H. Alder, R. Baffa, and C. M. Croce FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis PNAS, August 28, 2001; 98(18): 10374 - 10379. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
